openPR Logo
Press release

Pain Management Drugs Market 2018 Overview – Industry will Drive the Huge ROI by Size, Demand, Opportunities and Forecast 2017-2023

02-19-2019 03:01 PM CET | Health & Medicine

Press release from: Allied Market Research

Pain Management Drugs Market Size

Pain Management Drugs Market Size

Increase in prevalence of cancer and rise in number of surgeries conducted per year have fueled the demand for nonsteroidal anti-inflammatory drugs, and opioids in the market, thereby driving the market growth. As per the statistics provided by the World Bank, almost 4,511.1 surgeries were conducted per 100,000 population in 2012, which is further expected to supplement the market growth.

The Global Pain Management Drugs Market is estimated to reach from $58,577 million in 2016, $77,131 million by 2023. It is anticipated to register a CAGR of 4% during the forecast period, 2017-2023.

Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/404

Pain is a complex medical condition, which not only affects the physical but also mental well-being of an individual. It is caused due to trauma or tissue damage, and its intensity varies from person to person. Based on the cause of pain, the treatment provided can be a simple or complex. Pain can be managed with the help of a variety of pharmacological and non-pharmacological therapies.

The availability of sophisticated treatment options and advancement in technology have increased life the expectancy rates globally, which has resulted in an increase in the geriatric population. As the elderly people are highly prone to suffer from pain owing to various reasons, rise in elderly population is a major factor contributing towards the growth of the global pain management market. As per the statistics provided by the UN Population Division, the total proportion of people above 60 years has increased from 12% in 1950 to 22% in 2011, and is projected to reach 32% by 2050. Moreover, increase in R&D investment and rise in outsourcing of pharmaceuticals are expected to fuel the market growth in developing regions such as Asia-Pacific and LAMEA. However, availability of alternative therapies and patent expiration of prescription drugs for treatment of pain hamper the growth of the market.

The opioids segment is was the largest contributor towards the market growth in 2016, due to high efficiency of opioids to relieve pain in major chronic conditions. Anesthetics is anticipated to possess the highest growth rate during the forecast period.

Postoperative pain and chronic back pain were among the largest contributors in 2016, owing to increase in the number of surgeries globally and rise in prevalence of chronic diseases that lead to back pain. Furthermore, cancer pain is expected to grow at the highest rate throughout the forecast period, owing to rise in prevalence of cancer worldwide.

Get More Information @ https://www.alliedmarketresearch.com/connect-to-analyst/404

North America is expected to generate the highest revenue during forecast period. However, Asia-Pacific is projected to grow at the highest rate during 20172023, due to increase in government initiatives to improve the healthcare infrastructure and improved regulatory framework.

Key Findings of the Pain Management Drugs Market:

• Cancer pain segment is projected to grow at the highest rate during the analysis period.
• Opioids segment generated the highest revenue, and is expected to continue its dominance during the forecast period.
• North America occupied almost half of the market, and is projected to continue its dominance in future.
• China is expected to grow at a CAGR of 6% over the forecast period.
• Postoperative pain was the largest contributor among the indication segment in 2016.

The key companies profiled in the report include

• Novartis AG,
• Eli Lilly & Company,
• Abbott Laboratories,
• Endo Health Solutions, Inc.,
• Purdue Pharma L.P.,
• Pfizer, Inc.,
• F. Hoffmann La Roche Ltd.,
• Merck & Co. Inc.,
• Johnson & Johnson, and
• GlaxoSmithKline Plc.

Other prominent players in the value chain include Allergen Inc., Bayer AG, Bristol-Myers Squibb, Valeant Pharmaceuticals International Inc., Boehringer Ingelheim, Sorrento Therapeutics, WEX Pharmaceuticals, and Zynerba Pharmaceuticals.

Table Of Content

Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTER’S FIVE FORCES ANALYSIS
3.4. REGULATION AND REIMBURSEMENT SCENARIO
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Favorable regulatory scenario
3.5.1.2. Increase in geriatric population
3.5.1.3. Rise in incidence of chronic diseases
3.5.2. Restraints
3.5.2.1. Availability of alternative therapies
3.5.2.2. Drug exploitation
3.5.2.3. Patent expiration of prescription drugs
3.5.3. Opportunities
3.5.3.1. Advancements in drug development
3.5.3.2. Untapped markets in developing economies

Pain Management Drugs Market Summery @ https://www.alliedmarketresearch.com/press-release/pain-management-therapeutics-market.htmlmarket.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pain Management Drugs Market 2018 Overview – Industry will Drive the Huge ROI by Size, Demand, Opportunities and Forecast 2017-2023 here

News-ID: 1600393 • Views: 471

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Pain

Global Pain Management Drugs & Devices Market By Application - Burn Pain, Cancer …
Researchmoz added Most up-to-date research on "Global Pain Management Drugs & Devices Market By Application - Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain & Musculoskeletal Pain" to its huge collection of research reports. This report studies Pain Management Drugs & Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016,
Pain Management Devices Market
ReportsWorldwide has announced the addition of a new report title Pain Management Devices Market to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/pain-management-devices-market More than 100 million people in the US experience chronic pain. In Europe, the prevalence of chronic pain is between 25% and 35%. Pain-related disability represents a significant and costly liability to patients
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them
Targeting chronic pain
With the support of the Austrian Science Fund FWF, the neurophysiologist Ruth Drdla-Schutting is investigating the role astrocytes play in the genesis of chronic pain. With the help of innovative gene technology (DREADDs), scientists are tailoring treatment specifically to these cells that are the most numerous found in the central nervous system. Pain is an important protection system of the human body. But when it becomes chronic, as it frequently
Complex Regional Pain Syndrome
“Complex Regional Pain Syndrome Global 2016 Clinical Trials Review, H2" provides an detailed overview of Complex Regional Pain Syndrome scenario. Report includes top line data relating on Complex Regional Pain Syndrome Global clinical trials scenario. This report on Complex Regional Pain Syndrome also includes an review of trial numbers as well as their ( Complex Regional Pain Syndrome ) average enrollment in uppermost/top countries which are conducted worldwide. Complex Regional
Orthovisc- No More Pain
Orthovisc is a Hyaluronan formulation which stands effective in curing the knee joint pain. Joint pain caused due to osteoarthritis often keeps away people from taking part or enjoying a lot of things physically. Suffering from knee pain can create a lot of troubles in the life of the person suffering from it. In medical science, osteoarthritis is considered one of the most dreaded diseases which create a lot of